World's first international patient receives solid tumour CAR-T therapy Satri-cel in Shanghai
July 07, 2026 | 15:23
Jiahui International Cancer Center in Shanghai treated the world's first international patient with Satri-cel, the first approved CAR-T therapy for solid tumours, marking a milestone in extending access to China's frontier oncology treatments.
Mobile Version